AJAguinaldo F. Freitas Jr.

Aguinaldo F. Freitas Jr.

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aguinaldo F. Freitas Jr. has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Insuficiência Cardíaca Aguda em Pacientes com Cardiomiopatia Chagásica: Resultados do I Registro Brasileiro de Insuficiência Cardíaca (BREATHE)

    by Pedro Gabriel Melo de Barros E Silva, Denilson Campos Albuquerque, Renato Delascio Lopes, Paulo Roberto Nogueira, Aguinaldo F Freitas, Carlos Vieira Nascimento, Charles Mady, Elizabete Silva Dos Santos, Mauro Esteves Hernandes, Maria Alayde Mendonça Rivera, et al.

    Resumo Fundamentos Apesar de as características clínicas da Cardiomiopatia Chagásica Crônica (CCC) estarem bem estabelecidas, os dados clínicos sobre os pacientes são escassos. Objetivos Esta análise relata os resultados do I Registro Brasileiro de Insuficiência Cardíaca (BREATHE) avaliando as características basais e desfechos clínicos de pacientes com insuficiência cardíaca aguda secundária à CCC. Métodos O BREATHE incluiu 3013 pacientes adultos internados com insuficiência cardíaca aguda. Nós analisamos comparativamente 261 (8,7%) pacientes com CCC e 2752 (91,3%) pacientes com outras etiologias. Dados clínicos e demográficos, informações da estrutura e da função cardíaca no ecocardiograma e desfechos durante a internação hospitalar e após a alta foram avaliados em ambos os grupos. Testes univariados e multivariados foram realizados, e um p-valor < 0,05 foi considerado estatisticamente significativo. Resultados Pacientes com CCC apresentaram pressão arterial sistólica (108,3 ± 26,1 vs. 128,3 ± 30,3 mmHg, p<0,001) e fração de ejeção ventricular esquerda [25,4 (19 – 36)% vs. 37 (27 – 54) %, p<0,001) mais baixas, com taxas mais altas de distensão da veia jugular (54,8% vs. 38,9%, p<0,001), hepatomegalia (47,9% vs. 25,6%, p<0,001), e de perfil “frio e úmido” (27,2% vs. 10,6%, p<0,001). Pacientes com CCC apresentaram taxas mais altas do desfecho composto de morte ou transplante cardíaco (17,4% vs. 11,1%, p=0,004), e incidência cumulativa mais alta de morte após três meses (16,5% vs. 10,8%, p=0,017), seis meses (25,3% vs. 17,2%, p=0,006), e 12 meses (39,4% vs. 26,6%, p<0,001). Além disso, CCC associou-se independentemente com risco de mortalidade em 12 meses, com um odds ratio de 2,02 (IC95%: 1,47-2,77). Conclusão Em comparação a outras etiologias, os pacientes com CCC internados por insuficiência cardíaca aguda apresentaram um perfil de maior risco que foi associado com um pior desfecho durante a internação hospitalar e após a alta.


  • Open Access

    Acute Heart Failure in Patients with Chagas Cardiomyopathy: Results of the I Brazilian Heart Failure Registry (BREATHE)

    by Pedro Gabriel Melo de Barros e Silva, Denilson Campos Albuquerque, Renato Delascio Lopes, Paulo Roberto Nogueira, Aguinaldo F Freitas Jr, Carlos Vieira Nascimento, Charles Mady, Elizabete Silva dos Santos, Mauro Esteves Hernandes, Maria Alayde Mendonça Rivera, et al.

    Background Although the clinical features of chronic Chagas’ cardiomyopathy (CCC) have been well established, clinical data about the patients are scarce. Objectives The current analysis reports the results of the I Brazilian Heart Failure Registry (BREATHE) assessing baseline characteristics and clinical outcomes of patients with acute heart failure due to CCC. Methods BREATHE enrolled a total of 3,013 adult patients hospitalized with acute heart failure. We analyzed comparatively 261 (8.7%) patients with chronic CCC and 2,752 (91.3%) patients with other etiologies. Clinical and demographic information, cardiac structure/function data on echocardiogram and outcomes during the hospital stay and after discharge were assessed in both groups. Uni and multivariate tests were performed and a p-value <0.05 was considered statistically significant. Results Patients with CCC presented lower systolic blood pressure (108.3 ± 26.1 vs 128.3 ± 30.3 mmHg, p<0.001) and left ventricle ejection fraction (25.4 [19 - 36]% vs 37 [27 - 54] %, p<0.001) with higher rates of jugular vein distension (54.8% vs 38.9%, p<0.001), hepatomegaly (47.9% vs 25.6%, p<0.001), and “cold and wet” clinical hemodynamic profile (27.2% vs 10.6%, p<0.001). Patients with CCC presented higher rate of the composite death or heart transplantation (17.4% vs. 11.1%, p=0.004), and higher cumulative incidence of death after 3 months (16.5% vs 10.8%, p=0.017), 6 months (25.3% vs 17.2%, p=0.006), and 12 months (39.4% vs 26.6%, p<0.001). Besides, CCC was independently associated with 12-month mortality risk with odds ratio = 2.02 (95% IC: 1.47-2.77). Conclusion Patients with CCC, hospitalized due to acute heart failure, in comparison to other etiologies, presented a higher risk profile that was associated with a poorer outcome during hospital stay and after discharge.


  • Open Access

    Rosa dos Ventos Multicenter Cohort Study of Patients with Reduced or Mildly Reduced Ejection Fraction Heart Failure in Brazil: Rationale and Design

    by Dhayn Cassi de Almeida Freitas, Larissa Maria de Paula Rebouças da Costa, Wilson Nadruz Jr., Fabiana G. Marcondes-Braga, Jefferson Luis Vieira, Sabrina Bernardez-Pereira, Wilson Rodrigues Barbosa Neto, Silvia Marinho Martins Alves, Gabriela Arcoverde Wanderley, Camila Nogueira Leandro Lira, et al.

    Background: Brazil is a country with different biomes and social disparities. There are limited data available on regional differences and prognosis of heart failure (HF) in the country. Objective: The Rosa dos Ventos study aims to investigate regional differences and the current prognosis of HF outpatients with reduced or mildly reduced ejection fraction in Brazil. Methods: This is a prospective, multicenter, observational cohort study that will include outpatients older than 18 years with HF and an ejection fraction < 50% in 30 public and private centers distributed in all Brazilian regions. A total of 2,500 patients will be enrolled from June 2021 and October 2023, with a 12-month follow-up period. We will collect data on socioeconomic and clinical status, medical prescription and results of cardiology tests. Follow-up phone calls will be made at 6 and 12 months after inclusion to collect information regarding emergency room visits, hospitalization and mortality. Conclusion: The Rosa dos Ventos study will allow a more accurate characterization of chronic HF in Brazil. This initiative will provide relevant information for the development of effective management strategies to mitigate the impact of this condition on patients and the healthcare system.